NLRP3 and primary biliary cholangitis: There is evidence that the NLRP3 inflammasome and its downstream effectors are upregulated in cholestatic diseases in humans, e.g., biliary atresia, primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) [19,20,21].